JUL 17, 2018 11:30 PM PDT

Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR

A group of researchers are exploring a “trojan horse” tumor destruction model using the main tumor’s own cells.  They published their ideas and outcomes in the July 11, 2018 issue of Science Translational Medicine

Cancerous tumors are comprised of tumor cells that are dividing uncontrollably.  Some tumor cells will drift out into circulation and return to the main tumor site via a built in “homing” mechanism.  Researchers at Harvard have duped these roaming tumor cells into delivering cancer therapies directly to their main tumor, thereby initiating destruction of the main tumor.  Sounds like an in-body sci-fi experience written for a new fiction novel.

New gene editing technology, namely use of CRISPR-Cas9, is how this is actually possible.  Gene editing is the ability to change an organism’s physical DNA.  New sequences or genes can be added, removed, or modified within the genome.  CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9.  Bacteria use a similar genome editing mechanism naturally which is why bacteria have been primarily been used as vectors for genome editing up until very recently.  DNA is cut into small fragments and incorporated into a CRISPR locus so that when this is transcribed, the small RNAs have a new target which is then cut by the Cas9 enzyme.  In this study, the authors removed tumor cells and using CRISPR, created the expression of a death receptor on these tumor cells which causes cells to enter apoptosis.  These engineered tumor cells also included a mechanism whereby interaction with a particular drug would induce apoptosis of the engineered “trojan horse” tumor cell before it repopulated the main tumor site following loss of main tumor bulk or went on to start new tumor sites in the body. 

The study used mouse models with primary glioblastoma, recurrent glioblastoma, and breast cancer.  The therapeutic approach had discernable benefits for survival in mice; tumors were considerably reduced in size and reported that 90 percent of mice had increased survival weeks and months following the treatment intervention compared to the control mice (untreated) of which nearly 100 percent died within that same timeframe. 

There are still many unanswered questions surrounding this approach that need further investigation but the potential for using this particular unique “homing” feature of tumor cells is undeniable. 

Sources: Science Translational Medicine, NIH Genetics Home Reference, New England BioLabs, Scientific American,

 

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUL 18, 2018
Immunology
JUL 18, 2018
Immunotherapy Increases Survival of Melanoma Brain Metastases Patients
Use of Checkpoint Blockade Immunotherapy increases survival rates in Melanoma Brain Metastases patients, with a 4-year survival rate increase from 11.1% to 28.1%...
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
SEP 11, 2018
Cannabis Sciences
SEP 11, 2018
The Potential Anti-cancer Effects of Cannabinoids
They're known for helping to reduce the impact of cancer drug side effects, but it's possible that cannabinoids themselves are cancer fighters....
SEP 13, 2018
Cancer
SEP 13, 2018
Breast tumors can stop their own metastasis
According to the American cancer society, metastatic breast cancers or stage 4 breast cancers have 5-years survival rate of 22% which is lower than at early stages. Metastatic breast cancer...
DEC 09, 2018
Immunology
DEC 09, 2018
A Better Human Immune System: In Mice
We've cured cancer and autoimmune disease in mice many times over....
Loading Comments...